TITLE

Third-World Copycats to Emerging Multinationals: Institutional Changes and Organizational Transformation in the Indian Pharmaceutical Industry

AUTHOR(S)
Chittoor, Raveendra; Sarkar, M. B.; Ray, Sougata; Aulakh, Preet S.
PUB. DATE
January 2009
SOURCE
Organization Science;Jan/Feb2009, Vol. 20 Issue 1, p187
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article investigates how Indian pharmaceutical firms, facing discontinuous institutional changes in their domestic environment due to economic liberalization and intellectual property reforms, have undertaken organizational transformation. Internationalization of resources and product markets constitutes an important component of organizational transformation for local firms in emerging economies. Using longitudinal data on 206 Indian pharmaceutical firms from 1995--2004, we find that firms' access to international technological and financial resources enables product market internationalization. Furthermore, we theorize and find support for our predictions that the association between international resources and markets is conditioned by time and business group affiliation, and product market internationalization affects financial performance. Several implications thus emerge for theory and practice associated with the sources of competitiveness in emerging economy firms and their transformation into globally competitive multinational firms.
ACCESSION #
36606862

 

Related Articles

  • OD AND MULTINATIONAL CORPORATIONS. Murray, Francis T. // Training & Development Journal;Aug80, Vol. 34 Issue 8, p16 

    Discusses the use of organizational development (OD) to improve the relationship between developing countries and multinational corporations. Benefits of having intergroup meetings; Use of OD techniques and mechanisms to reduce or eliminate conflicts of interest; Comprehensive overview of work...

  • Development of Nations in the Global Economy. Gould, Marie // Development of Nations in the Global Economy -- Research Starter;4/1/2018, p1 

    This paper will focus on how people react to the different types of innovations used in developing countries as they attempt to develop in ways that allow them to compete on a global basis. Many had the perception that the international community should be doing more to close the gap between...

  • Lilly Announces Strategic Changes to its Global Manufacturing Operations.  // BioPharm International;Mar2007, Vol. 20 Issue 3, p18 

    The article announces the strategic changes of Eli Lilly and Co. on its global manufacturing operations. The changes were made to better support the company's product portfolio and evolving drug pipeline. The construction of the planned insulin manufacturing plant located in Prince William...

  • "Why Change Succeeds:" An Organizational Self-Assessment. Cowley, Bill // Organization Development Journal;Summer2007, Vol. 25 Issue 2, pP25 

    This paper seeks to explain the underlying reasons for the success or failure of 11 corporate-level change initiatives in a large international pharmaceutical company. A research team comprised of internal and external specialists interviewed 72 employees who were involved in the implementation...

  • Caracterização da trajetória de desenvolvimento da indústria farmacêutica na Índia: elementos para aprendizado. Radaelli, Vanderleia; Paranhos, Julia // Parcerias Estratégicas;jun2013, Vol. 18 Issue 36, p9 

    Lately, certain developing countries have managed to gain important market shares in the pharmaceutical industry. While in many of these the strategies, governance and regulatory system for innovation are still being consolidated, this group of countries nevertheless has attracted the interest...

  • Bioprospecting--why is it so unrewarding?  // Biodiversity & Conservation;Feb2003, Vol. 12 Issue 2, p207 

    Attempts to answer the question of why large multinational pharmaceutical and agrochemical companies spend very little of their research effort on bioprospecting, or searching for new biologically active chemicals in organisms, in less developed countries, and presents an alternative scenario...

  • Transforming the Pharmaceutical Industry: Human Resources as Global Catalyst. John, Steve // Organization Development Journal;Summer2007, Vol. 25 Issue 2, pP139 

    This paper discusses the post-merger transformation of the regional/country based Human Resources organizations of a multinational pharmaceutical company that will be referred to in this paper as APC (A Pharmaceutical) Company. APC initiated its integration planning in late 1999 with a global...

  • Toward a Geocentric Theory of Multinational Evolution: The Implications from the Asian MNEs as Latecomers.  // Asia Pacific Journal of Management;Jun2003, Vol. 20 Issue 2, p217 

    Focuses on Asian multinational enterprises (MNEs). Rise in MNEs from the developing countries; Problems related to MNEs from developing countries; Perception of MNEs from the developing countries as latecomers.

  • Producing prosperity. Islam, Shujaat // Harvard International Review;Spring93, Vol. 15 Issue 3, p42 

    Discusses issues of multinational investment in less-developed countries (LDCs). Better position for LDCs to capitalize on foreign direct investment; Reasons for the success of lesser-known multinational corporations; Benefits enjoyed by an LDC that encourage the activities of smaller...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics